Tonghua Golden-Horse Pharmaceutical Industry CoLtd Balance Sheet Health
Financial Health criteria checks 1/6
Tonghua Golden-Horse Pharmaceutical Industry CoLtd has a total shareholder equity of CN¥2.3B and total debt of CN¥1.7B, which brings its debt-to-equity ratio to 73.1%. Its total assets and total liabilities are CN¥4.5B and CN¥2.1B respectively. Tonghua Golden-Horse Pharmaceutical Industry CoLtd's EBIT is CN¥124.6M making its interest coverage ratio 1.6. It has cash and short-term investments of CN¥181.1M.
Key information
73.1%
Debt to equity ratio
CN¥1.69b
Debt
Interest coverage ratio | 1.6x |
Cash | CN¥181.12m |
Equity | CN¥2.32b |
Total liabilities | CN¥2.15b |
Total assets | CN¥4.47b |
Recent financial health updates
Recent updates
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd's (SZSE:000766) Popularity With Investors Is Under Threat From Overpricing
Aug 20Tonghua Golden-Horse Pharmaceutical Industry CoLtd (SZSE:000766) Seems To Use Debt Quite Sensibly
Jun 03Should You Be Adding Tonghua Golden-Horse Pharmaceutical Industry CoLtd (SZSE:000766) To Your Watchlist Today?
May 12Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SZSE:000766) Stock Rockets 34% As Investors Are Less Pessimistic Than Expected
Mar 06Financial Position Analysis
Short Term Liabilities: 000766's short term assets (CN¥1.0B) exceed its short term liabilities (CN¥512.0M).
Long Term Liabilities: 000766's short term assets (CN¥1.0B) do not cover its long term liabilities (CN¥1.6B).
Debt to Equity History and Analysis
Debt Level: 000766's net debt to equity ratio (65.3%) is considered high.
Reducing Debt: 000766's debt to equity ratio has increased from 11.7% to 73.1% over the past 5 years.
Debt Coverage: 000766's debt is not well covered by operating cash flow (11.5%).
Interest Coverage: 000766's interest payments on its debt are not well covered by EBIT (1.6x coverage).